Literature DB >> 14596803

The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS.

Bryan M Edwards1, Steven C Barash, Sarah H Main, Gil H Choi, Ralph Minter, Stephen Ullrich, Elizabeth Williams, Leila Du Fou, Jane Wilton, Vivian R Albert, Steve M Ruben, Tristan J Vaughan.   

Abstract

It is well established that the humoral immune response can generate antibodies to many different antigens. The antibody diversity required to achieve this is believed to be substantial. However, the extent to which the immune repertoire can generate structural diversity against a single target antigen has never been addressed. Here, we have used phage display to demonstrate the extraordinary capacity of the human antibody repertoire. Over 1000 antibodies, all different in amino acid sequence, were generated to a single protein, B-lymphocyte stimulator (BLyS protein). This is a highly diverse panel of antibodies as exemplified by the extensive heavy and light chain germline usage: 42/49 functional heavy chain germlines and 19/33 V(lambda) and 13/35 V(kappa) light chain germlines were all represented in the panel of antibodies. Moreover, a high level of sequence diversity was observed in the V(H) CDR3 domains of these antibodies, with 568 different amino acid sequences identified. Thus we have demonstrated that specific recognition of a single antigen can be achieved from many different VDJ combinations, illustrating the remarkable problem-solving ability of the human immune repertoire. When studied in a biochemical assay, around 500 (40%) of these antibodies inhibited the binding of BLyS to its receptors on B-cell lines. The most potent antibodies inhibited BLyS binding with sub-nanomolar IC(50) values and with sub-nanomolar affinities. Such antibodies provide excellent choices as candidates for the treatment of BLyS-associated autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596803     DOI: 10.1016/j.jmb.2003.09.054

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Generation of scFv phages specific to Staphylococcus enterotoxin C1 by panning on related antigens.

Authors:  Anna V Lomonosova; Alexander G Laman; Ksenia K Fursova; Anna O Shepelyakovskaya; Yury V Vertiev; Fedor A Brovko; Evgeny V Grishin
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

Review 2.  New tools for classification and monitoring of autoimmune diseases.

Authors:  Holden T Maecker; Tamsin M Lindstrom; William H Robinson; Paul J Utz; Matthew Hale; Scott D Boyd; Shai S Shen-Orr; C Garrison Fathman
Journal:  Nat Rev Rheumatol       Date:  2012-05-31       Impact factor: 20.543

3.  On the influence of vector design on antibody phage display.

Authors:  Glenn Soltes; Michael Hust; Kitty K Y Ng; Aasthaa Bansal; Johnathan Field; Donald I H Stewart; Stefan Dübel; Sanghoon Cha; Erik J Wiersma
Journal:  J Biotechnol       Date:  2006-09-22       Impact factor: 3.307

4.  Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells.

Authors:  Anna N Melidoni; Michael R Dyson; Sam Wormald; John McCafferty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

5.  Large scale production of phage antibody libraries using a bioreactor.

Authors:  Fortunato Ferrara; Chang-Yub Kim; Leslie A Naranjo; Andrew R M Bradbury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Characterization of human IgG repertoires in an acute HIV-1 infection.

Authors:  Weizao Chen; Ponraj Prabakaran; Zhongyu Zhu; Yang Feng; Emily D Streaker; Dimiter S Dimitrov
Journal:  Exp Mol Pathol       Date:  2012-10-01       Impact factor: 3.362

7.  Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.

Authors:  Claire L Dobson; Sarah Main; Philip Newton; Matthieu Chodorge; Karen Cadwallader; Robin Humphreys; Vivian Albert; Tristan J Vaughan; Ralph R Minter; Bryan M Edwards
Journal:  MAbs       Date:  2009-11-11       Impact factor: 5.857

Review 8.  Deep sequencing in library selection projects: what insight does it bring?

Authors:  J Glanville; S D'Angelo; T A Khan; S T Reddy; L Naranjo; F Ferrara; A R M Bradbury
Journal:  Curr Opin Struct Biol       Date:  2015-08       Impact factor: 6.809

9.  VNAR single-domain antibodies specific for BAFF inhibit B cell development by molecular mimicry.

Authors:  Julien Häsler; Martin F Flajnik; Gareth Williams; Frank S Walsh; J Lynn Rutkowski
Journal:  Mol Immunol       Date:  2016-05-20       Impact factor: 4.407

10.  Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker.

Authors:  Fortunato Ferrara; Leslie A Naranjo; Sandeep Kumar; Tiziano Gaiotto; Harshini Mukundan; Basil Swanson; Andrew R M Bradbury
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.